Lung Cancer — 5-Minute Journal Club Issue 4 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates episode artwork

EPISODE · Nov 10, 2025 · 21 MIN

Lung Cancer — 5-Minute Journal Club Issue 4 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

from Lung Cancer Update

Dr Aaron Lisberg from the University of California, Los Angeles, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer. CME information and select publications here.

Episode metadata supplied by the publisher feed · Published Nov 10, 2025

Embed this episode

Ready to play

Lung Cancer — 5-Minute Journal Club Issue 4 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

0:00 21:21

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Lung Cancer Update?

This episode is 21 minutes long.

When was this Lung Cancer Update episode published?

This episode was published on November 10, 2025.

Can I download this Lung Cancer Update episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!